• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体β亚型在胰腺腺癌中的表达

Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma.

作者信息

Younes Mamoun, Ly Charles J, Singh Kanchan, Ertan Atilla, Younes Pamela S, Bailey Jennifer M

机构信息

Departments of Pathology and Laboratory Medicine, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.

Department of Medicine, Section of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, USA.

出版信息

Oncotarget. 2018 Dec 28;9(102):37715-37720. doi: 10.18632/oncotarget.26503.

DOI:10.18632/oncotarget.26503
PMID:30701026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6340876/
Abstract

Limited studies have shown that some patients with pancreatic adenocarcinoma (PAC) may benefit from treatment with tamoxifen. PAC has been shown to be largely negative for estrogen receptor alpha (ER-alpha). The aim of this pilot study was to investigate ER-beta expression in human PAC. Sections of tissue microarray with 18 evaluable cases of human PAC were stained by immunohistochemistry (IHC) for ER-beta1, ER-beta2, ER-beta5, and Cyclin A. The levels of ER-beta isoform expression and the S-phase fraction (SPF) were determined using quantitative digital image analysis. Higher mean and median ER-beta2 levels correlated with male sex ( = 0.057 and = 0.035, respectively), older age ( = 0.005 and = 0.006, respectively), and lower pT stage ( = 0.008 and = 0.009). Mean and median ER-beta5 levels correlated negatively with SPF ( = 0.021 and = 0.047, respectively). Mean ER-beta1 expression did not correlate with any of the above mentioned clinicopathologic factors. The findings in this pilot study, although should be considered preliminary, suggest that some ER-beta isoforms may play a role in the biology of PAC. Additional larger studies are needed to confirm our findings, and to determine whether ER-beta may be considered for future targeted therapy.

摘要

有限的研究表明,一些胰腺腺癌(PAC)患者可能从他莫昔芬治疗中获益。已证明PAC在很大程度上雌激素受体α(ER-α)呈阴性。本初步研究的目的是调查人PAC中ER-β的表达情况。对包含18例可评估的人PAC组织微阵列切片进行免疫组织化学(IHC)染色,检测ER-β1、ER-β2、ER-β5和细胞周期蛋白A。使用定量数字图像分析确定ER-β亚型表达水平和S期分数(SPF)。较高的ER-β2平均水平和中位数水平分别与男性(分别为 = 0.057和 = 0.035)、老年(分别为 = 0.005和 = 0.006)以及较低的pT分期(分别为 = 0.008和 = 0.009)相关。ER-β5的平均水平和中位数水平与SPF呈负相关(分别为 = 0.021和 = 0.047)。ER-β1的平均表达与上述任何临床病理因素均无相关性。本初步研究的结果虽然应被视为初步的,但表明一些ER-β亚型可能在PAC生物学中发挥作用。需要更多更大规模的研究来证实我们的发现,并确定ER-β是否可被考虑用于未来的靶向治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/57f9fb1518d2/oncotarget-09-37715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/5221e8f05d27/oncotarget-09-37715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/53b380c2bb4c/oncotarget-09-37715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/57f9fb1518d2/oncotarget-09-37715-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/5221e8f05d27/oncotarget-09-37715-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/53b380c2bb4c/oncotarget-09-37715-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffbf/6340876/57f9fb1518d2/oncotarget-09-37715-g003.jpg

相似文献

1
Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma.雌激素受体β亚型在胰腺腺癌中的表达
Oncotarget. 2018 Dec 28;9(102):37715-37720. doi: 10.18632/oncotarget.26503.
2
CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity.CRM1/XPO1在胰腺腺癌中的表达与生存素表达及增殖活性相关。
Oncotarget. 2018 Apr 20;9(30):21289-21295. doi: 10.18632/oncotarget.25088.
3
Expression of estrogen receptor beta correlates with adverse prognosis in resected pancreatic adenocarcinoma.雌激素受体β的表达与可切除胰腺腺癌的不良预后相关。
BMC Cancer. 2018 Oct 29;18(1):1049. doi: 10.1186/s12885-018-4973-6.
4
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.雌激素受体β评估在接受辅助他莫昔芬治疗的乳腺癌患者中的临床意义。
J Clin Oncol. 2008 Aug 1;26(22):3727-34. doi: 10.1200/JCO.2007.14.2968.
5
Quantitative analysis of estrogen receptor-alpha and -beta messenger RNA expression in human pancreatic cancers by real-time polymerase chain reaction.通过实时聚合酶链反应对人胰腺癌中雌激素受体-α和-β信使核糖核酸表达进行定量分析。
Cancer Lett. 2001 Sep 10;170(1):91-7. doi: 10.1016/s0304-3835(01)00563-8.
6
[Evaluation of wild-type estrogen receptor beta and its isoforms: ER-beta/delta 5/6 i ER-beta/delta 6 in endometrial adenocarcinoma].[野生型雌激素受体β及其异构体:子宫内膜腺癌中的ER-β/δ5/6和ER-β/δ6的评估]
Ginekol Pol. 2003 Sep;74(9):897-902.
7
Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.雌激素受体β1、β2和β5信使核糖核酸在人乳腺组织中的表达。
Cancer Res. 1999 Mar 15;59(6):1175-9.
8
Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues.雌激素受体β2的鉴定,一种在正常大鼠组织中表达的雌激素受体β的功能变体。
Endocrinology. 1998 Mar;139(3):1082-92. doi: 10.1210/endo.139.3.5840.
9
Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.雌激素受体(ER)-β亚型:理解ER-β信号传导的关键
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13162-7. doi: 10.1073/pnas.0605676103. Epub 2006 Aug 22.
10
Modulation of estrogen receptor-beta isoforms by phytoestrogens in breast cancer cells.植物雌激素对乳腺癌细胞中雌激素受体-β亚型的调节作用。
Int J Oncol. 2006 May;28(5):1185-91.

引用本文的文献

1
Integrative pan-cancer analysis reveals a common architecture of dysregulated transcriptional networks characterized by loss of enhancer methylation.综合泛癌分析揭示了以增强子甲基化缺失为特征的转录网络失调的共同架构。
PLoS Comput Biol. 2024 Nov 18;20(11):e1012565. doi: 10.1371/journal.pcbi.1012565. eCollection 2024 Nov.
2
Characterization of Estrogen Receptors in Pancreatic Adenocarcinoma with Tertiary Lymphoid Structures.具有三级淋巴结构的胰腺腺癌中雌激素受体的特征分析
Cancers (Basel). 2023 Jan 29;15(3):828. doi: 10.3390/cancers15030828.

本文引用的文献

1
CRM1/XPO1 expression in pancreatic adenocarcinoma correlates with survivin expression and the proliferative activity.CRM1/XPO1在胰腺腺癌中的表达与生存素表达及增殖活性相关。
Oncotarget. 2018 Apr 20;9(30):21289-21295. doi: 10.18632/oncotarget.25088.
2
Cancer Statistics, 2017.《2017 年癌症统计》
CA Cancer J Clin. 2017 Jan;67(1):7-30. doi: 10.3322/caac.21387. Epub 2017 Jan 5.
3
Pancreatic Cancer: A Review.胰腺癌:综述
Gastroenterol Clin North Am. 2016 Sep;45(3):429-45. doi: 10.1016/j.gtc.2016.04.003.
4
Estrogen receptor β.雌激素受体β。
Arch Pathol Lab Med. 2011 Jan;135(1):63-6. doi: 10.5858/2010-0448-RAR.1.
5
Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.雌激素受体β评估在接受辅助他莫昔芬治疗的乳腺癌患者中的临床意义。
J Clin Oncol. 2008 Aug 1;26(22):3727-34. doi: 10.1200/JCO.2007.14.2968.
6
Estrogen receptor beta/alpha ratio predicts response of pancreatic cancer cells to estrogens and phytoestrogens.雌激素受体β/α比值可预测胰腺癌细胞对雌激素和植物雌激素的反应。
J Surg Res. 2007 Jun 1;140(1):55-66. doi: 10.1016/j.jss.2006.10.015. Epub 2007 Feb 1.
7
Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status.回复:无论雌激素受体状态如何,他莫昔芬可能是治疗BRCA1相关乳腺癌的有效方法。
J Natl Cancer Inst. 2003 Apr 16;95(8):629-30. doi: 10.1093/jnci/95.8.629.
8
Differential expression of the estrogen receptor beta (ERbeta) in human prostate tissue, premalignant changes, and in primary, metastatic, and recurrent prostatic adenocarcinoma.雌激素受体β(ERβ)在人前列腺组织、癌前病变以及原发性、转移性和复发性前列腺腺癌中的差异表达。
Prostate. 2003 Feb 1;54(2):79-87. doi: 10.1002/pros.10171.
9
Estrogen receptor-beta expression in hereditary breast cancer.遗传性乳腺癌中雌激素受体-β的表达
J Clin Oncol. 2002 Sep 1;20(17):3752-3; author reply 3753. doi: 10.1200/JCO.2002.99.116.
10
Estrogen receptor-beta is expressed in Barrett's metaplasia and associated adenocarcinoma of the esophagus.雌激素受体-β在巴雷特化生及相关食管腺癌中表达。
Anticancer Res. 2002 May-Jun;22(3):1459-61.